Page 613 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 613

CHAPTER 33  Agents Used in Cytopenias; Hematopoietic Growth Factors        599



                       Folic Acid Supplementation: A Public Health Dilemma

                       Starting in January 1998, all products made from enriched grains in   Although the potential benefits of supplemental folic acid
                       the United States and Canada were required to be supplemented   during pregnancy are compelling, the decision to require
                       with folic acid. These rulings were issued to reduce the incidence of   folic acid in grains was controversial. As described in the text,
                       congenital neural tube defects (NTDs). Epidemiologic studies show   ingestion of folic acid can partially or totally correct the anemia
                       a strong correlation between maternal folic acid deficiency and   caused by vitamin B 12  deficiency. However, folic acid supple-
                       the incidence of NTDs such as spina bifida and anencephaly. The   mentation does not prevent the potentially irreversible neu-
                       requirement for folic acid supplementation is a public health mea-  rologic damage caused by vitamin B 12  deficiency. People with
                       sure aimed at the significant number of women who do not receive   pernicious anemia and other forms of vitamin B 12  deficiency
                       prenatal care and are not aware of the importance of adequate   are usually identified because of signs and symptoms of ane-
                       folic acid ingestion for preventing birth defects in their infants.   mia, which typically occur before neurologic symptoms. Some
                       Observational studies from countries that supplement grains with   opponents of folic acid supplementation were concerned that
                       folic acid have found that supplementation is associated with a   increased  folic acid  intake  in  the  general population  would
                       significant (20–25%) reduction in NTD rates. Observational stud-  mask vitamin B 12  deficiency and increase the prevalence of
                       ies also suggest that rates of other types of congenital anomalies   neurologic disease in the elderly population.  To put this in
                       (heart and orofacial) have fallen since supplementation began.  perspective, approximately 4000 pregnancies, including 2500
                                                               5
                         There may be an added benefit for adults.  N -Methyl-  live births, in the United States each year are affected by NTDs.
                       tetrahydrofolate is required for the conversion of homocysteine   In contrast, it is estimated that more than 10% of the elderly
                       to methionine (Figure 33–2; Figure 33–3, reaction 1). Impaired   population in the United States, or several million people, are at
                                 5
                       synthesis of N -methyltetrahydrofolate results in elevated serum   risk for the neuropsychiatric complications of vitamin B 12  defi-
                       concentrations of homocysteine. Data from several sources sug-  ciency. In acknowledgment of this controversy, the FDA kept
                       gest a positive correlation between elevated serum homocysteine   its requirements for folic acid supplementation at a somewhat
                       and occlusive vascular diseases such as ischemic heart disease and   low level.  There is also concern based on observational and
                       stroke. Clinical data suggest that the folate supplementation pro-  prospective clinical trials that high folic acid levels can increase
                       gram has improved the folate status and reduced the prevalence   the risk of some diseases, such as colorectal cancer, for which
                       of hyperhomocysteinemia in a population of middle-aged and   folic acid may exhibit a bell-shaped curve. Further research is
                       older adults who did not use vitamin supplements. There is also   needed to more accurately define the optimal level of folic acid
                       evidence that adequate folic acid protects against several cancers,   fortification in food and recommendations for folic acid supple-
                       including colorectal, breast, and cervical cancer.  mentation in different populations and age groups.



                    though the deficiency is easily corrected by administration of folic   Pharmacokinetics
                    acid. The consequences of folate deficiency go beyond the prob-  The  average  American  diet  contains  500–700  mcg  of  folates
                    lem of anemia because folate deficiency is implicated as a cause   daily, 50–200 mcg of which is usually absorbed, depending on
                    of congenital malformations in newborns and may play a role in   metabolic requirements. Pregnant women may absorb as much
                    vascular disease (see Box: Folic Acid Supplementation: A Public   as 300–400 mcg of folic acid daily. Various forms of folic acid are
                    Health Dilemma).
                    Chemistry
                                                                          H N   N    N
                                                                           2
                    Folic acid (pteroylglutamic acid) is composed of a heterocycle                      COO –  Polyglutamation
                    (pteridine), p-aminobenzoic acid, and glutamic acid (Figure 33–4).   N  CH                     site
                    Various numbers of glutamic  acid moieties are  attached to the   N    2            CH 2
                    pteroyl portion of the molecule, resulting in monoglutamates,   OH  HN              CH 2
                                                                             Pteridine
                    triglutamates,  or  polyglutamates. Folic acid undergoes  reduc-  derivative  C  H  CH
                                                                                                     N
                    tion, catalyzed by the enzyme dihydrofolate reductase (“folate
                    reductase”), to give dihydrofolic acid (Figure 33–3, section 3).        PABA  O     COO –
                    Tetrahydrofolate is subsequently transformed to folate cofactors   Pteroyl (pteroic acid)  Glutamic acid
                    possessing one-carbon units attached to the 5-nitrogen, to the
                    10-nitrogen, or to both positions (Figure 33–3). Folate cofactors   Folic acid
                    are interconvertible by various enzymatic reactions and serve the
                    important biochemical function of donating one-carbon units at   FIGURE 33–4  The structure of folic acid. (Reproduced, with
                    various levels of oxidation. In most of these, tetrahydrofolate is   permission, from Murray RK et al: Harper’s Biochemistry, 24th ed. McGraw-Hill, 1996.
                    regenerated and becomes available for reutilization.  Copyright © The McGraw-Hill Companies, Inc.)
   608   609   610   611   612   613   614   615   616   617   618